Showing 7 of 7 recruiting trials for “epithelioid-sarcoma”
SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
👨⚕️ Robert Maki, MD, MPH, Memorial Sloan Kettering Cancer Center📍 6 sites📅 Started Dec 2025View details ↗
A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors
RecruitingNCT06408441 ↗
The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
Evaluate the Safety and Clinical Activity of HH2853
RecruitingNCT04300257 ↗
Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care
RecruitingNCT03099681 ↗
An Observational Study on Epithelioid Sarcoma
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →